Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ASCO Annual Meeting 2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

2024 ASCO Annual Meeting

Keep up to date with all the top stories and latest evidence with our hub page, including official congress videos and expert takeaways.
ADVANCED SEARCH
Log in
Top
Current Bladder Dysfunction Reports
Published in: Current Bladder Dysfunction Reports 2/2012

01-06-2012 | Neurogenic Bladder (F Daneshgari, Section Editor)

Neurogenic Bladder in Pediatrics and Adolescents

Authors: Peter P. Stuhldreher, Edward E. Cherullo, Robert Kohut

Published in: Current Bladder Dysfunction Reports | Issue 2/2012

Login to get access

Abstract

Neurogenic bladder in the pediatric population underwent an evolution in treatment patterns during the 20th century. This paradigm change began with an evolving understanding of the health risks children with this condition face and the variable pathophysiology resulting in their condition. Introduction of clean intermittent catheterization and anticholinergic medication revolutionized care of these young patients. Advances in our knowledge of bladder pathology, and novel techniques to improve lower urinary tract function have made a variety of treatments available to patients. Although some similarities exist between adult and pediatric neurogenic bladder, the pediatric patient provides unique challenges with growth and development and helping children gain independence. Presented is a review of the treatment options and an algorithm to support the two main goals of treatment: protection of the upper urinary tract from renal function deterioration and development of social continence.
Literature
1.
Thompson DNP. Spinal dysraphic anomalies; classification, presentation and management. Paediatr Child Health. 2010;20(9):397–403.CrossRef
2.
Abrahamsson K, Olsson I, Sillén U. Urodynamic findings in children with myelomeningocele after untethering of the spinal cord. J Urol. 2007;177(1):331–4.PubMedCrossRef
3.
Kaefer M, Pabby A, Kelly M, Darbey M, Bauer SB. Improved bladder function after prophylactic treatment of the high risk neurogenic bladder in newborns with myelomeningocele. J Urol. 1999;162:1068–71.PubMedCrossRef
4.
Generao SE, Dall’Era JP, Stone AR, Kurzrock EA. Spinal cord injury in children: long-term urodynamic and urological outcomes. J Urol. 2004;172(3):1092–4.PubMedCrossRef
5.
6.
Silveri M, Salsano L, Pierro MM, Mosiello G, Capitanucci ML, De Gennaro M. Pediatric spinal cord injury: approach for urological rehabilitation and treatment. J Pediatr Urol. 2006;2(1):10–5.PubMedCrossRef
7.
Tanaka ST, Stone AR, Kurzrock EA. Transverse myelitis in children: long-term urological outcomes. J Urol. 2006;175(5):1865–8.PubMedCrossRef
8.
Decter RM, Bauer SB, Khoshbin S, et al. Urodynamic assessment of children with cerebral palsy. J Urol. 1987;138(4 Pt 2):1110–2.PubMed
9.
Morrisroe SN, O’Connor RC, Nanigian DK, Kurzrock EA, Stone AR. Vesicostomy revisited: the best treatment for the hostile bladder in myelodysplastic children? BJU Int. 2005;96(3):397–400.PubMedCrossRef
10.
Lapides J, Diokno AC, Silber SM, Lowe BS. Clean, intermittent self-catheterization in the treatment of urinary tract disease. J Urol. 1972;107:458–61.PubMed
11.
Anagnostopoulos D, Joannides E, Kotsianos K. The urological management of patients with myelodysplasia. Pediatr Surg Int. 1988;3:347–50.CrossRef
12.
Holzbeierlein J, Pope JC, Adams MC, Bruner J, Tylipan N, Brock JW. The urodynamic profile of myelodysplasia in childhood with spinal closure during gestation. J Urol. 2000;164:1336–9.PubMedCrossRef
13.
Edelstein RA, Bauer SB, Kelly M, et al. The long-term urological response of neonates with myelodysplasia treated proactively with intermittent catheterization and anticholinergic therapy. J Urol. 1995;154:1500–4.PubMedCrossRef
14.
Klose A, Sackett C, Mesrobian H. Management of children with myelodysplasia: urological alternatives. J Urol. 1990;144:1446–9.PubMed
15.
Tanaka H, Kazizaki H, Kobayashi S, Shibata T, Ameda K, Koyanagi T. The relevance of urethral resistance in children with myelodysplasia: its impact on upper urinary tract deterioration and the outcome of conservative management. J Urol. 1999;161:929–32.PubMedCrossRef
16.
McGuire EJ, Woodside JR, Borden TA, Weiss RM. Prognostic value of urodynamic testing in myelodysplastic patients. J Urol. 1981;126:205–9.PubMed
17.
Palmer LS, Richards I, Kaplan W. Age related bladder capacity and bladder capacity growth in children with myelomeningocele. J Urol. 1997;158:1261–4.PubMedCrossRef
18.
Painter KA, Vates TS, Bukowski TP, et al. Long-term intravesical oxybutynin chloride therapy in children with myelodysplasia. J Urol. 1996;156:1459–62.PubMedCrossRef
19.
Palmer LS, Zebold K, Firlit CF, Kaplan WE. Complications of intravesical oxybutynin chloride therapy in the pediatric myelomeningocele population. J Urol. 1997;157:638–40.PubMedCrossRef
20.
Altaweel W, Jednack R, Bilodeau C, Corcos J. Repeated intradetrusor botulinum toxin type A in children with neurogenic bladder due to myelomeningocele. J Urol. 2006;175(3):1102–5.PubMedCrossRef
21.
22.
Pascali MP, Mosiello G, Boldrini R, Salsano ML, Castelli E, De Gennaro M. Effects of botulinum toxin Type A in the bladder wall of children with neurogenic bladder dysfunction: a comparison of histological features before and after injections. J Urol. 2011;185(6):2552–7.PubMedCrossRef
23.
Hoebeke P, De Caestecker K, Vande Walle J, et al. The effect of botulinum-A toxin in Incontinent children with therapy resistant overactive detrusor. J Urol. 2006;176(1):328–31.PubMedCrossRef
24.
Schulte-Baukloh H, Michael T, Stürzebecher B, Knispel HH. Botulinum-A toxin detrusor injection as a novel approach in the treatment of bladder spasticity in children with neurogenic bladder. Eur Urol. 2003;44(1):139–43.PubMedCrossRef
25.
• De Gennaro M, Capitanucci ML, Mosiello G, Zaccara A. Current state of nerve stimulation technique for lower urinary tract dysfunction in children. J Urol. 2011;185(5):1571–7. This study gives an excellent review of data behind nerve stimulation in children, and future directions in research.PubMedCrossRef
26.
• Clark C, Ngo T, Comiter CV, Anderson R, Kennedy W. Sacral nerve stimulator revision due to somatic growth. J Urol. 2011;186(4):1576–80. This study provides an example of the data needed in the pediatric population regarding nerve stimulation. Though it is a very small sample size, this helps build knowledge and efficacy data on the use of sacral stimulation.PubMedCrossRef
27.
Quek ML, Ginsberg DA. Long-term urodynamics followup of bladder augmentation for neurogenic bladder. J Urol. 2003;169:195–8.PubMedCrossRef
28.
Medel R, Ruarte AC, Herrera M, Castera R, Podesta ML. Urinary continence outcome after augmentation ileocystoplasty as a single surgical procedure in patients with myelodysplasia. J Urol. 2002;168:1849–52.PubMedCrossRef
29.
DeFoor W, Minevich E, Reddy P, et al. Bladder calculi after augmentation cystoplasty: risk factors and prevention strategies. J Urol. 2004;172(5):1964–6.PubMedCrossRef
30.
Leyland JW, Masters JG. Conservative management of an intraperitoneal rupture of an augmentation cystoplasty and continent urinary diversion in an adult. J Urol. 2003;170(2):524.PubMedCrossRef
31.
Soergel TM, Cain MP, Misseri R, Gardner TA, Koch MO, Rink RC. Transitional cell carcinoma of the bladder following augmentation cystoplasty for the neuropathic bladder. J Urol. 2004;172(4):1649–52.PubMedCrossRef
32.
• Kokorowski PJ, Routh JC, Borer JG, Estrada CR, Bauer SB, Nelson CP. Screening for malignancy after augmentation cystoplasty in children with spina bifida: a decision analysis. J Urol. 2011;186(4):1437–43. This study gives a good, realistic approach to screening for patients after augmentation. It provides support that patients should be counseled preoperatively about a small risk of malignancy.PubMedCrossRef
33.
Sundaram CP, Reinberg Y, Aliabadi HA. Failure to obtain durable results with collagen implantation in children with urinary incontinence. J Urol. 1997;157:2306–7.PubMedCrossRef
34.
Austin PF, Westney OL, Leng WW, McGuire EJ, Ritchey M. Advantages of rectus fascial slings for uinary incontinence in children with neuropathic bladder. J Urol. 2001;165:2369–72.PubMedCrossRef
35.
Castera R, Podesta ML, Ruarte AC, Herrera M, Medel R. 10-year experience with artificial urinary sphincter in children and adolescents. J Urol. 2001;165:2373–6.PubMedCrossRef
36.
Hajlvassilou CA. A review of the complications and results of implantation of the AMS artificial urinary sphincter. Eur Urol. 1999;35(1):36–44.CrossRef
37.
Holmes NM, Kogan BA, Baskin LS. Placement of artificial urinary sphincter in children and simultaneous gastrocystoplasty. J Urol. 2001;165:2366–8.PubMedCrossRef
38.
Catto J, Natarajan V, Tophill P. Simultaneous augmentation cystoplasty is associated with earlier rather than increased artificial urinary sphincter infection. J Urol. 2005;173(4):1237–41.PubMedCrossRef
Metadata
Title
Neurogenic Bladder in Pediatrics and Adolescents
Authors
Peter P. Stuhldreher
Edward E. Cherullo
Robert Kohut
Publication date
01-06-2012
Publisher
Current Science Inc.
Published in
Current Bladder Dysfunction Reports / Issue 2/2012
Print ISSN: 1931-7212
Electronic ISSN: 1931-7220
DOI
https://doi.org/10.1007/s11884-012-0131-1

Other articles of this Issue 2/2012

Current Bladder Dysfunction Reports 2/2012 Go to the issue

Neurogenic Bladder (F Daneshgari, Section Editor)

Xiao Procedure for Neurogenic Bladder in Spinal Cord Injury and Spina Bifida

Neurogenic Bladder (F Daneshgari, Section Editor)

Management of the Bladder in Spinal Cord Injury Patients

Infectious Bladder Dysfunction (MS Mourad, Section Editor)

GAG Layer Replenishment Therapy for Recurrent Infectious Bladder Dysfunction

Neurogenic Bladder (F Daneshgari, Section Editor)

Lower Urinary Tract Dysfunction in Multiple Sclerosis

Infectious Bladder Dysfunction (MS Mourad, Section Editor)

Recurrent Urinary Tract Infections Associated with Gynecological Disorders

Infectious Bladder Dysfunction (MS Mourad, Section Editor)

HIV-Induced Cystopathy